Bank of America’s Urovant Sciences Ltd. UROV Stock Holding History

Bank of America’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-64,000	Closed	-$1.03M	–	8025
2020 Q4	$1.03M	Buy	64,000 +63,967	+193,839%	+$793K	﹤0.01%	4473
2020 Q3	$0	Sell	33 -5	-13%	-$44	﹤0.01%	7348
2020 Q2	$0	Buy	+38	New	+$364	﹤0.01%	7300
2019 Q4	–	Sell	-1,463	Closed	-$14K	–	7593
2019 Q3	$14K	Buy	+1,463	New	+$12.7K	﹤0.01%	6660

Bank of America's UROV Position: Q1 2021 in Review

Bank of America sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 64,000 shares — an estimated $1.03M sold.

Bank of America first reported a position in UROV in Q3 2019 and held it in 4 quarters. The position peaked at $1.03M in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

Bank of America reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Bank of America sold 64,000 Urovant Sciences Ltd. shares in Q1 2021, an estimated $1.03M.
Bank of America first reported a position in Urovant Sciences Ltd. in Q3 2019 and held it in 4 quarters.
Bank of America's Urovant Sciences Ltd. position peaked at $1.03M in Q4 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Bank of America's 13F filing for Q1 2021, filed 14 May 2021.